American Cancer Society. Cancer Facts and Figures 2012. Atlanta, Ga: American Cancer Society; 2012.
American Joint Committee on Cancer. Vulvar Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010:379–386.
Ault KA, Future II study group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet. 2007 Jun 2;369(9576):1861–1868.
Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer. 2003 Dec 10;107(5):804-10.
Bosquet JG, Magrina JF, Gaffey TA, et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gyn Onc 2005;97:828–833
Burke TW, Russell AH. Advanced-stage vulvar cancer. In: Gynecologic Cancer: Controversies in Management. Gershenson D, Gore M, McGuire W, Quinn M, Thomas G, editors. Elsevier Science, pp 105–112. 2004.
Castellsagué X, Bosch FX, Muñoz N, Meijer CJ, et al. Male circumcision, penile human papilloma virus infection, and cervical cancer in female partners. N Engl J Med. 2002 Apr 1; 346(15):1105-1112.
Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626-629.
Creasman WT, Phillips JL, Menck HR. The National Cancer Database report on early stage invasive vulvar carcinoma. Cancer. 1997;80:505–513.
Eifel PJ, Berek JS, Markman MA.. Cancer of the Cervix, Vagina and Vulva. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 8th edition. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008:1295–1340.
Flannelly G. Preinvasive diseases of the cervix, vagina, and vulva. In: Gynecologic Cancer: Controversies in Management. Gershenson D, Gore M, McGuire W, Quinn M, Thomas G, editors. Elsevier Science, pp 79–92. 2004.
FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010 Jul 20;341:c3493
Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007 May 10;356(19):1928–1943
Gray RH, Serwadda D, Kong X, Makumbi F, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis. 2010 May 15;201(10):1455-1462.
Kenter GG, Welters MJ, Valentijn AR, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med. 2009 Nov 5;361(19):1838–1847.
Kosary CL. Cancer of the Vulva. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007
Levenback CF, van der Zee AG, Rob L, et al. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol. 2009 Aug;114(2):151–156.
Lu B, Wu Y, Nielson CM, Flores R, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis. 2009 Feb 1;199(3):362-371.
Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst. 1997 Oct 15;89(20):1516–1523.
Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina--population-based case-control study in Denmark. Int J Cancer. 2008 Jun 15;122(12):2827–2834.
Olawaiye A, Lee LM, Krasner C, Horowitz N. Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol. 2007 Sep;106(3):628–630. Epub 2007 Jun 11.
Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009 Jul 25;374(9686):301–314.
PDQ database. Vulvar Cancer. Bethesda, Md: National Cancer Institute; 8/5/2010. Accessed at http://www.cancer.gov/cancertopics/pdq/treatment/vulvar/HealthProfessional on April 13, 2011.
Richard SD, Krivak TC, Beriwal S, Zorn KK. Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab. Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1132–1135. Epub 2007 Nov 16.
Rotmensch J, Yamada SD. Neoplasms of the vulva and vagina. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E. Cancer Medicine 6. Hamilton, Ont: BC Decker; 2003. 1769–1777.
Rouzier R, Haddad B, Atallah D, et al. Surgery for vulvar cancer. Clin Obst Gyn 2005;48:869–878.
Saslow D, Solomon D, Lawson H, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. CA Cancer J Clin. In press.
Society of Gynecologic Oncologists Clinical Practice Guidelines: Vulvar cancer. Oncology. 1998;12:275–282.
Van der Avoort IAM, Shirango H, Hovenaars BM, et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gyn Path 2005;25:22–29.
Van der Velden J. Controversies in early vulvar cancer. In: Gynecologic Cancer: Controversies in Management. Gershenson D, Gore M, McGuire W, Quinn M, Thomas G, editors. Elsevier Science, pp 93–103, 2004.
van Seters M, van Beurden M, ten Kate FJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008 Apr 3;358(14):1465–1473.
Feedback
